Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stoke Therapeutics (STOK) Non-cash Items (2022 - 2024)

Historic Non-cash Items for Stoke Therapeutics (STOK) over the last 3 years, with Q4 2024 value amounting to $4.3 million.

  • Stoke Therapeutics' Non-cash Items fell 4915.98% to $4.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.3 million, marking a year-over-year decrease of 4915.98%. This contributed to the annual value of $4.3 million for FY2024, which is 629.21% up from last year.
  • Stoke Therapeutics' Non-cash Items amounted to $4.3 million in Q4 2024, which was down 4915.98% from $8.4 million recorded in Q4 2023.
  • In the past 5 years, Stoke Therapeutics' Non-cash Items registered a high of $20.6 million during Q4 2022, and its lowest value of $4.3 million during Q4 2024.
  • Moreover, its 3-year median value for Non-cash Items was $8.4 million (2023), whereas its average is $11.1 million.
  • As far as peak fluctuations go, Stoke Therapeutics' Non-cash Items plummeted by 5904.94% in 2023, and later crashed by 4915.98% in 2024.
  • Stoke Therapeutics' Non-cash Items (Quarter) stood at $20.6 million in 2022, then plummeted by 59.05% to $8.4 million in 2023, then tumbled by 49.16% to $4.3 million in 2024.
  • Its Non-cash Items stands at $4.3 million for Q4 2024, versus $8.4 million for Q4 2023 and $20.6 million for Q4 2022.